Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients
- PMID: 1375802
- DOI: 10.1111/j.1600-0447.1992.tb01474.x
Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients
Abstract
The ventricle-brain ratio (VBR) of 42 chronic schizophrenic patients was compared with that of 42 age-matched medical controls. For the schizophrenics, the relationship of various clinical parameters to the VBR was assessed, and the outcome of 12 weeks of double-blind treatment with either risperidone or haloperidol. The results confirm that schizophrenic patients have slightly enlarged lateral ventricles compared with medical controls. Only for schizophrenics, an effect of age, but not of duration of illness, was noticed. This study does not support the validity of a clinical subdivision of chronic schizophrenic patients on the basis of the VBR. Neither negative, positive nor general psychopathological symptoms, as measured by the Positive and Negative Syndrome Scale for Schizophrenia (PANSS), were related to the VBR, nor were abnormal involuntary movements or extrapyramidal symptoms. No association between season of birth or a family history of major mental disorder and VBR could be demonstrated. Treatment response was predicted by the total PANSS score and the PANSS general psychopathology subscale score at baseline. There was a trend for patients with higher VBR to have a more or haloperidol). or haloperidol).
Similar articles
-
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.J Clin Psychopharmacol. 1993 Feb;13(1):25-40. J Clin Psychopharmacol. 1993. PMID: 7683702 Clinical Trial.
-
Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.Pharmacopsychiatry. 1993 Jul;26(4):121-4. Pharmacopsychiatry. 1993. PMID: 7694306 Clinical Trial.
-
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.Hum Psychopharmacol. 2012 Jan;27(1):24-32. doi: 10.1002/hup.1254. Epub 2011 Dec 7. Hum Psychopharmacol. 2012. PMID: 22161738 Clinical Trial.
-
Clinical review of risperidone.Can J Psychiatry. 1993 Sep;38 Suppl 3:S89-95. Can J Psychiatry. 1993. PMID: 7504574 Review.
-
Pathophysiology and treatment of negative symptoms.Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S53-8. Can J Psychiatry. 1994. PMID: 7533052 Review.
Cited by
-
Study factors influencing ventricular enlargement in schizophrenia: a 20 year follow-up meta-analysis.Neuroimage. 2012 Jan 2;59(1):154-67. doi: 10.1016/j.neuroimage.2011.07.011. Epub 2011 Jul 20. Neuroimage. 2012. PMID: 21787868 Free PMC article.
-
Anatomical variants of the posterior horns of the lateral ventricles: an MRI study.Front Neuroimaging. 2025 Apr 7;4:1478137. doi: 10.3389/fnimg.2025.1478137. eCollection 2025. Front Neuroimaging. 2025. PMID: 40260117 Free PMC article.
-
Antipsychotic medication for early episode schizophrenia.Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD006374. doi: 10.1002/14651858.CD006374.pub2. Cochrane Database Syst Rev. 2011. PMID: 21678355 Free PMC article.
-
Effect of Season of Birth on Hippocampus Volume in a Transdiagnostic Sample of Patients With Depression and Schizophrenia.Front Hum Neurosci. 2022 Jun 13;16:877461. doi: 10.3389/fnhum.2022.877461. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35769255 Free PMC article.
-
Risperidone versus typical antipsychotic medication for schizophrenia.Cochrane Database Syst Rev. 2000;2003(2):CD000440. doi: 10.1002/14651858.CD000440. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2003;(2):CD000440. doi: 10.1002/14651858.CD000440. PMID: 10796543 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical